Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04039061

ADPKD Patient Registry

Autosomal Dominant Polycystic Kidney Disease Patient Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
PKD Foundation · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of the ADPKD Registry is to create an online patient network that includes at least 5,000 people with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who contribute data on their health and other topics. The ADPKD Patient Registry aims to support important scientific discoveries and support patient needs in the following ways: * Connect ADPKD patients with opportunities to join clinical studies. * Collect data for the research community to better describe the ADPKD disease experience and improve patient care. * Engage with patients by measuring quality of life outcomes.

Detailed description

The ADPKD Registry will be a patient-powered network of people with ADPKD. This data will inform new research to improve ADPKD patient outcomes, learn more about the patient journey and discover unmet medical needs. We collect data most relevant to your ADPKD diagnosis, its major symptoms and management, as well as key demographic data (no personally identifiable information is shared). A Registry keeps information in one place making it easier for researchers to utilize Registry information while still protecting the privacy of those who take part. The Registry will be hosted on a secure, online platform that patients can access using their home computers, tablets or phones. The purpose of the ADPKD Registry is to allow PKD patients to: * Connect with researchers and express interest in taking part in certain clinical studies for ADPKD, including studies of new medications and other treatments. * Take confidential health-related surveys. These surveys are aimed at better understanding of the health of people with PKD across their lifespans.

Conditions

Timeline

Start date
2019-09-04
Primary completion
2029-09-04
Completion
2029-09-04
First posted
2019-07-31
Last updated
2023-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04039061. Inclusion in this directory is not an endorsement.